{"id":9050,"date":"2022-10-17T10:37:18","date_gmt":"2022-10-17T08:37:18","guid":{"rendered":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/"},"modified":"2022-10-17T10:37:18","modified_gmt":"2022-10-17T08:37:18","slug":"clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future","status":"publish","type":"events","link":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/","title":{"rendered":"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future"},"content":{"rendered":"

Adaptive Platform Trials: The Clinical Trial of the Future<\/strong><\/p>

This lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.<\/p>

About the speaker:<\/strong><\/p>

Dr. Ariel Dora Stern is the Poronui Associate Professor of Business Administration in the Technology and Operations Management Unit at Harvard Business School,\u00a0where she teaches the course \u201cTransforming Health Care Delivery.\u201d Ariel’s research\u00a0focuses on technology management and innovation in health care. Her projects consider the regulation, strategy, and economics of health care, with a focus on understanding the drivers of new product development among firms and the determinants of how new medical technologies are adopted and used in practice. She is a faculty affiliate of Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health and the Harvard-MIT Center for Regulatory Science. From 2020-2021 Ariel served as the Director for International Health Care Economics at the Health Innovation Hub, the independent think tank of the German Federal Ministry of Health and from 2021-2022, as a Visiting Scholar at the Digital Health Center of The Hasso Plattner Institute. She is a member of the Scientific Advisory Board of the German Society for Digital Medicine and advises health care start-ups.<\/p>

<\/p>

Tuesday 6 December – 16:00-17:30, Hybrid Meeting<\/p>

Centre Hospitalier du Luxembourg (CHL) – Amphitheater<\/p>

& WebEx: https:\/\/tinyurl.com\/innovhealth4<\/a><\/p>

[access code: 273 442 59834<\/p>

password: mZtbPXHf344 (69827943 from phones)]<\/p>

For on-site and remote registration, please drop an email to: Bianca.dragomir@lih.lu<\/a><\/p>

This lecture series is organised jointly by the Prof. Rejko Kru\u0308ger and Prof. Jochen Klucken on behalf of the research groups Translational Neuroscience (LCSB), Transversal Translational Medicine (LIH), and Digital Medicine (LIH, LCSB).<\/p><\/div><\/section>","protected":false},"excerpt":{"rendered":"

Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.<\/p>\n","protected":false},"author":0,"featured_media":9051,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","format":"standard","meta":{"featured_image_focal_point":[],"show_featured_caption":false,"ulux_newsletter_groups":"","uluxPostTitle":"","uluxPrePostTitle":"","_trash_the_other_posts":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"event_start_date":"2022-12-06 16:00:00","event_end_date":"2022-12-06 17:30:00","event_speaker_name":"Dr Ariel Dora Stern","event_speaker_link":"","event_is_online":false,"event_location":"Centre Hospitalier du Luxembourg (CHL) Amphitheatre","event_street":"4 Rue Nicolas Ernest Barbl\u00e9","event_location_link":"","event_zip_code":"1210","event_city":"Luxembourg","event_country":"LU"},"events-topic":[],"events-type":[],"organisation":[202,226],"authorship":[],"acf":[],"yoast_head":"\nClinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future - Universit\u00e9 du Luxembourg<\/title>\n<meta name=\"description\" content=\"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future\" \/>\n<meta property=\"og:description\" content=\"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/\" \/>\n<meta property=\"og:site_name\" content=\"UNI FR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/uni.lu\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/\",\"url\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/\",\"name\":\"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future - Universit\u00e9 du Luxembourg\",\"isPartOf\":{\"@id\":\"https:\/\/www.uni.lu\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg\",\"datePublished\":\"2022-10-17T08:37:18+00:00\",\"dateModified\":\"2022-10-17T08:37:18+00:00\",\"description\":\"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage\",\"url\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg\",\"contentUrl\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg\",\"width\":800,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.uni.lu\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\/\/www.uni.lu\/fr\/events\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.uni.lu\/fr\/#website\",\"url\":\"https:\/\/www.uni.lu\/fr\/\",\"name\":\"Uni.lu\",\"description\":\"Universit\u00e9 du Luxembourg\",\"publisher\":{\"@id\":\"https:\/\/www.uni.lu\/fr\/#organization\"},\"alternateName\":\"Universit\u00e9 du Luxembourg\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.uni.lu\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.uni.lu\/fr\/#organization\",\"name\":\"Universit\u00e9 du Luxembourg\",\"alternateName\":\"Uni.lu\",\"url\":\"https:\/\/www.uni.lu\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.uni.lu\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg\",\"contentUrl\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg\",\"width\":2560,\"height\":2560,\"caption\":\"Universit\u00e9 du Luxembourg\"},\"image\":\"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/04\/24120552\/20200609-Belval-Campus_Henri-Goergen-23.jpg\",\"sameAs\":[\"https:\/\/www.facebook.com\/uni.lu\",\"https:\/\/www.linkedin.com\/school\/university-of-luxembourg\/\",\"https:\/\/www.instagram.com\/uni.lu\",\"https:\/\/www.youtube.com\/@uni_lu\",\"https:\/\/en.wikipedia.org\/wiki\/University_of_Luxembourg\"],\"email\":\"communication@uni.lu\",\"telephone\":\"+352 46 66 44 1\",\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"2, place de l\u2019Universit\u00e9\",\"addressLocality\":\"Esch-sur-Alzette\",\"postalCode\":\"4365\",\"addressCountry\":\"LU\"},\"description\":\"Universit\u00e9 du Luxembourg\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future - Universit\u00e9 du Luxembourg","description":"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/","og_locale":"fr_FR","og_type":"article","og_title":"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future","og_description":"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.","og_url":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/","og_site_name":"UNI FR","article_publisher":"https:\/\/www.facebook.com\/uni.lu","og_image":[{"width":2560,"height":2560,"url":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/","url":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/","name":"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future - Universit\u00e9 du Luxembourg","isPartOf":{"@id":"https:\/\/www.uni.lu\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage"},"image":{"@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage"},"thumbnailUrl":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg","datePublished":"2022-10-17T08:37:18+00:00","dateModified":"2022-10-17T08:37:18+00:00","description":"Adaptive Platform Trials: The Clinical Trial of the FutureThis lecture will present an overview of Adaptive Platform Trails (APTs), including key definitions and design considerations. It will then present a brief case study of GBM AGILE, a large-scale, international APT for glioblastoma that is currently underway at dozens of clinical sites, with multiple interventional trial arms. While statistically rigorous and still considered the \u201cgold standard\u201d in clinical research, traditional RCTs are time-consuming, costly, and remain limited to testing just one new therapy at a time. APTs, by contrast, facilitate simultaneously studying multiple therapies for a given disease and promise several efficiency improvements. They also use Bayesian statistical techniques to allow more patients access to promising therapies. As such, they hold the potential to fundamentally change the clinical research process, making clinical trials for new therapies more efficient, more accessible to patients, and more ambitious in scope. Yet new considerations emerge in the financing, regulatory science, and management of APTs. These will be discussed broadly and in the case of GBM AGILE in particular.","breadcrumb":{"@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#primaryimage","url":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg","contentUrl":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2022\/10\/clinical_research_on_innovative_healthcare_adaptive_platform_trials_the_clinical_trial_of_the_future.jpg","width":800,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.uni.lu\/fr\/events\/clinical-research-on-innovative-healthcare-adaptive-platform-trials-the-clinical-trial-of-the-future\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.uni.lu\/fr\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/www.uni.lu\/fr\/events\/"},{"@type":"ListItem","position":3,"name":"Clinical research on Innovative Healthcare: Adaptive Platform Trials: The Clinical Trial of the Future"}]},{"@type":"WebSite","@id":"https:\/\/www.uni.lu\/fr\/#website","url":"https:\/\/www.uni.lu\/fr\/","name":"Uni.lu","description":"Universit\u00e9 du Luxembourg","publisher":{"@id":"https:\/\/www.uni.lu\/fr\/#organization"},"alternateName":"Universit\u00e9 du Luxembourg","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.uni.lu\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.uni.lu\/fr\/#organization","name":"Universit\u00e9 du Luxembourg","alternateName":"Uni.lu","url":"https:\/\/www.uni.lu\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.uni.lu\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg","contentUrl":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/03\/03120045\/UNIV_SM-Profile_1600x1600px-scaled.jpg","width":2560,"height":2560,"caption":"Universit\u00e9 du Luxembourg"},"image":"https:\/\/www.uni.lu\/wp-content\/uploads\/sites\/11\/2026\/04\/24120552\/20200609-Belval-Campus_Henri-Goergen-23.jpg","sameAs":["https:\/\/www.facebook.com\/uni.lu","https:\/\/www.linkedin.com\/school\/university-of-luxembourg\/","https:\/\/www.instagram.com\/uni.lu","https:\/\/www.youtube.com\/@uni_lu","https:\/\/en.wikipedia.org\/wiki\/University_of_Luxembourg"],"email":"communication@uni.lu","telephone":"+352 46 66 44 1","address":{"@type":"PostalAddress","streetAddress":"2, place de l\u2019Universit\u00e9","addressLocality":"Esch-sur-Alzette","postalCode":"4365","addressCountry":"LU"},"description":"Universit\u00e9 du Luxembourg"}]}},"_links":{"self":[{"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/events\/9050"}],"collection":[{"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/types\/events"}],"replies":[{"embeddable":true,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/comments?post=9050"}],"version-history":[{"count":0,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/events\/9050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/media\/9051"}],"wp:attachment":[{"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/media?parent=9050"}],"wp:term":[{"taxonomy":"events-topic","embeddable":true,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/events-topic?post=9050"},{"taxonomy":"events-type","embeddable":true,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/events-type?post=9050"},{"taxonomy":"organisation","embeddable":true,"href":"https:\/\/www.uni.lu\/fr\/wp-json\/wp\/v2\/organisation?post=9050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}